Evidence map›Paper›PMID 31432212›Full record

ArticlePlant cell reports2019

Production of bacteriophage-encoded endolysin, LysP11, in Nicotiana benthamiana and its activity as a potent antimicrobial agent against Erysipelothrix rhusiopathiae.

Md Reyazul Islam, Namil Son, Junho Lee, Dong Wook Lee, Eun-Ju Sohn, Inhwan Hwang

Abstract read
PubMed Publisher
In one paragraph

Article in Plant cell reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. An endolysin gene fromHorticulture research · 2023
    Article
  5. Plants (Basel, Switzerland) · 2022
    Article
  6. Article
  7. Review
  8. Article
  9. Phage Therapy in Veterinary Medicine.Antibiotics (Basel, Switzerland) · 2021
    Review
  10. Frontiers in plant science · 2020
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Md Reyazul IslamDivision of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, 37673, South Korea.
Namil SonDivision of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, 37673, South Korea.
Junho LeeDivision of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, 37673, South Korea.
Dong Wook LeeDivision of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, 37673, South Korea.
Eun-Ju SohnBioApplications Inc., Pohang, 37668, South Korea.
Inhwan HwangDivision of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology, Pohang, 37673, South Korea. ihhwang@postech.ac.kr.
Pohang University of Science and Technology · KRPohang TechnoPark (South Korea) · KR

Funding

Cooperative Research Program for Agriculture Science and Technology Development PJ010953012019Ministry of Trade, Industry and Energy 10063301Next-Generation BioGreen 21 Program PJ01335801Next-Generation BioGreen 21 Program PJ01365001
6 · The paper itself

Abstract

key messageWe produced a biologically active phage-encoded endolysin, LysP11, in N. benthamiana. Plant-produced LysP11 exhibited robust antimicrobial activity against E. rhusiopathiae, and C-terminal domain of LysP11 bound specifically to E. rhusiopathiae. Bacterial resistance to antibiotics, a serious issue in terms of global public health, is one of the leading causes of death today. Thus, new antimicrobial agents are needed to combat pathogens. Recent research suggests that bacteriophages and endolysins derived from bacteriophages are potential alternatives to traditional antibiotics. Here, we examined the antimicrobial activity of LysP11, which is encoded by Propionibacterium phage P1.1 and comprises an N-terminal amidase-2 domain and a C-terminal domain with no homology to other bacteriophage endolysins. LysP11 was produced in Nicotiana benthamiana (N. benthamiana) using an Agrobacterium-mediated transient expression strategy. LysP11 was purified on microcrystalline cellulose-binding resin after attachment of the Clostridium thermocellum-derived family 3 cellulose-binding domain as an affinity tag. The affinity tag was removed using the small ubiquitin-related modifier (SUMO) domain and SUMO-specific protease. Plant-produced LysP11 showed strong antimicrobial activity toward Erysipelothrix rhusiopathiae (E. rhusiopathiae), mediated via lysis of the cell wall. Lytic activity was optimal at pH 8.0-9.0 (37 °C) and increased at higher concentrations of NaCl up to 400 mM. Furthermore, the C-terminal domain of LysP11 bound specifically to the E. rhusiopathiae cell wall. Based on these results, we propose that LysP11 is a potential candidate antimicrobial agent against E. rhusiopathiae.

Indexed as

Anti-Infective AgentsCell WallEndopeptidasesErysipelothrixNicotianaAnti-Infective AgentsendolysinEndopeptidasesCellulose-binding domainEndolysinErysipelothrix rhusiopathiaeLysP11Nicotiana benthamianaPlant-based expression systems

Identifiers

PMID31432212
OpenAlexW2969780028

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.